Biovail Declares Quarterly Dividend
2010年8月5日 - 7:59PM
ビジネスワイヤ(英語)
Biovail Corporation (NYSE, TSX: BVF) today announced that the
Company’s Board of Directors has declared a quarterly cash dividend
of US$0.095 per share payable on October 4, 2010 to shareholders of
record at the close of business September 1, 2010. The ex-dividend
date is August 30, 2010.
Important Income-Tax Information for Canadian Resident
Shareholders
Biovail Corporation designates the entire amount of this taxable
dividend to be an “eligible dividend” for purposes of the Income
Tax Act (Canada), as amended from time to time. This notice meets
the requirements of the Income Tax Act (Canada). Please contact
your tax advisor if you have any questions with regard to the
designation of the eligible dividend.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company
engaged in the formulation, clinical testing, registration,
manufacture, and commercialization of pharmaceutical products. The
Company is focused on the development and commercialization of
medicines that address unmet medical needs in niche specialty
central nervous system (CNS) markets. For more information about
Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at
905-286-3000 or send inquiries to ir@biovail.com.
Biovail (NYSE:BVF)
過去 株価チャート
から 5 2024 まで 6 2024
Biovail (NYSE:BVF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Biovail Corp (ニューヨーク証券取引所): 0 recent articles
その他のBiovail Corporationニュース記事